Cite
HARVARD Citation
Carter, A. et al. (n.d.). CDK5 Activation Drives Pancreatic Neuroendocrine Tumorigenesis and is a Therapeutic Target. HPB. pp. S58-S59. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Carter, A. et al. (n.d.). CDK5 Activation Drives Pancreatic Neuroendocrine Tumorigenesis and is a Therapeutic Target. HPB. pp. S58-S59. [Online].